ABIVAX Société Anonyme

NasdaqGM:ABVX Stock Report

Market Cap: US$542.0m

ABIVAX Société Anonyme Management

Management criteria checks 2/4

ABIVAX Société Anonyme's CEO is Marc M. de Garidel, appointed in May 2023, has a tenure of 1.5 years. total yearly compensation is €793.97K, comprised of 45.3% salary and 54.7% bonuses, including company stock and options. directly owns 0.06% of the company’s shares, worth $326.70K. The average tenure of the management team and the board of directors is 1.3 years and 3.3 years respectively.

Key information

Marc M. de Garidel

Chief executive officer

€794.0k

Total compensation

CEO salary percentage45.3%
CEO tenure1.5yrs
CEO ownership0.06%
Management average tenure1.3yrs
Board average tenure3.3yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Marc M. de Garidel's remuneration changed compared to ABIVAX Société Anonyme's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024n/an/a

-€177m

Mar 31 2024n/an/a

-€163m

Dec 31 2023€794k€359k

-€148m

Compensation vs Market: Marc M.'s total compensation ($USD833.30K) is below average for companies of similar size in the US market ($USD2.14M).

Compensation vs Earnings: Insufficient data to compare Marc M.'s compensation with company performance.


CEO

Marc M. de Garidel (66 yo)

1.5yrs

Tenure

€793,971

Compensation

Mr. Marc M. P. de Garidel, M.B.A., serves as Director of Claris Biotherapeutics, Inc. He serves as CEO at ABIVAX Société Anonyme since May 5, 2023 amd serves as its Director. He had been its Interim Chair...


Leadership Team

NamePositionTenureCompensationOwnership
Marc M. de Garidel
CEO & Director1.5yrs€793.97k0.060%
$ 326.7k
Philippe Pouletty
Founder & Directorno data€35.00k0.43%
$ 2.4m
Didier Blondel
EVP, CFO & Board Secretary7.8yrsno data0.00059%
$ 3.2k
Didier Scherrer
Chief Scientific Officer1.3yrsno data0.057%
$ 306.4k
Patrick Malloy
Senior Vice President of Investor Relations1.3yrsno datano data
Ida Hatoum
Chief People & Compliance Officer1.4yrsno datano data
Pierre Courteille
Chief Business Officerno datano data0%
$ 0
Jerome Denis
Executive Vice President of Process Development & Manufacturing1.2yrsno datano data
Ana Sharma
VP & Global Head of Qualityless than a yearno datano data
Hema Keshava
Senior Vice President of Financeno datano datano data
Chris Rabbat
VP & Global Head of Medical Affairsno datano datano data
Kevin Shan
VP & Global Head of Biometricsno datano datano data

1.3yrs

Average Tenure

57.5yo

Average Age

Experienced Management: ABVX's management team is not considered experienced ( 1.3 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Marc M. de Garidel
CEO & Director1.5yrs€793.97k0.060%
$ 326.7k
Philippe Pouletty
Founder & Director10.9yrs€35.00k0.43%
$ 2.4m
Sylvie Gregoire
Chair of the Boardless than a yearno datano data
Christian Trepo
Member of Scientific Advisory Boardno datano datano data
Lawrence Stanberry
Member of Scientific Advisory Boardno datano datano data
Troy Ignelzi
Independent Director1.3yrs€44.33kno data
Christoph Huber
Member of Scientific Advisory Boardno datano datano data
Claude Bertrand
Member of Scientific Advisory Board5.1yrs€4.94kno data
Luc Teyton
Member of Scientific Advisory Boardno datano datano data
June Lee
Independent Director1.3yrs€35.24kno data
Corinna Bonsen-Thomas
Independent Non-Executive Director7.4yrs€135.16k0%
$ 0
Ian McGowan
Chairman of Scientific Advisory Board6.4yrsno datano data

3.3yrs

Average Tenure

63.5yo

Average Age

Experienced Board: ABVX's board of directors are considered experienced (3.3 years average tenure).